Article in Science translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
21 authors.
L K Metthew LamCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0001-9700-4988
Theron GillilandCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0001-8373-0057
Matthew DunnCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0003-0378-5838
Maria D Alcorn-BurckhardtCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0001-8211-3647
Yutaka TeradaCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Chengqun SunCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Shauna VasilatosCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0009-0003-2688-1571
Morgan MidgettCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Connor WilliamsCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0009-0007-5315-6964
Amanda LaughlinCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0009-0002-4285-2108
Jeneveve LundyCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Christina L GardnerVirology Division, United States Army Military Institute for Infectious Diseases, Frederick, MD 21702, USA.ORCID 0000-0002-3475-8966
Archana ThomasOregon Health & Science University, Beaverton, OR 97006, USA.ORCID 0000-0002-5943-5004
Hans-Peter RauéOregon Health & Science University, Beaverton, OR 97006, USA.
Hans P GertjeNational Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA.
Aoife K O'ConnellNational Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA.
Nicholas A CrosslandNational Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA.ORCID 0000-0003-3873-9188
Douglas S ReedCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0003-0076-9023
Michael S DiamondDepartments of Medicine, Molecular Microbiology, Pathology and Immunology and the Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-8791-3165
William B KlimstraCenter for Vaccine Research and Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.ORCID 0000-0003-4506-7842
Funding
Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
An Informed Approach to Live Attenuated Vaccines against Encephalitis AlphavirusesR01AI153209 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2020 to 2024
$2.9M
Vectra Polaris Quantitative Pathology Imaging SystemS10OD030269 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2021 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques. · full record | OpenQuestion